117 related articles for article (PubMed ID: 18279371)
1. The genetic differences with whole genome linkage disequilibrium mapping between responder and non-responder in interferon-alpha and ribavirin combined therapy for chronic hepatitis C patients.
Chen PJ; Hwang Y; Lin CG; Wu YJ; Wu LS
Int J Immunogenet; 2008 Apr; 35(2):153-7. PubMed ID: 18279371
[TBL] [Abstract][Full Text] [Related]
2. Interleukin 28B-related polymorphisms: a pathway for understanding hepatitis C virus infection?
Garcia RF; Moreira S; de Araújo Ramos AL; Ferreira LE; de Mattos AA; Tovo CV; Nader LA; Ramos JA; Rondinelli E; de Jesus Dominici A; Garcia CE; de Souza Leite Pinho M; Brandão-Mello CE; Villela-Nogueira CA; de França PH
World J Gastroenterol; 2013 Nov; 19(42):7399-404. PubMed ID: 24259970
[TBL] [Abstract][Full Text] [Related]
3. No association between the IL28B SNP and response to peginterferon plus ribavirin combination treatment in Korean chronic hepatitis C patients.
Heo NY; Lim YS; Lee W; Oh M; An J; Lee D; Shim JH; Kim KM; Lee HC; Lee YS; Suh DJ
Clin Mol Hepatol; 2014 Jun; 20(2):177-84. PubMed ID: 25032184
[TBL] [Abstract][Full Text] [Related]
4. Effect of IL15 rs10833 and SCARB1 rs10846744 on virologic responses in chronic hepatitis C patients treated with pegylated interferon-α and ribavirin.
Sadeghi S; Davari M; Asli E; Gharibzadeh S; Vaziri F; Jamnani FR; Fateh A; Siadat SD
Gene; 2017 Sep; 630():28-34. PubMed ID: 28827115
[TBL] [Abstract][Full Text] [Related]
5. Confounding by Single Nucleotide Polymorphism rs117648444 (P70S) Affects the Association of Interferon Lambda Locus Variants with Response to Interferon-α-Ribavirin Therapy in Patients with Chronic Genotype 3 Hepatitis C Virus Infection.
Bhushan A; Ghosh S; Bhattacharjee S; Chinnaswamy S
J Interferon Cytokine Res; 2017 Aug; 37(8):369-382. PubMed ID: 28727946
[TBL] [Abstract][Full Text] [Related]
6. Pegylated interferon alpha-2a and -2b in combination with ribavirin in the treatment of chronic hepatitis C: a systematic review and economic evaluation.
Shepherd J; Brodin H; Cave C; Waugh N; Price A; Gabbay J
Health Technol Assess; 2004 Oct; 8(39):iii-iv, 1-125. PubMed ID: 15461877
[TBL] [Abstract][Full Text] [Related]
7. Comment on: 'interleukin-28 polymorphisms on the SVR in the treatment of naïve chronic hepatitis C with pegylated interferon-α plus ribavirin: a meta-analysis'.
Fernández-Rodríguez A; Jiménez-Sousa MÁ; Resino S
Gene; 2013 Jun; 522(1):121. PubMed ID: 23506831
[No Abstract] [Full Text] [Related]
8. Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C.
Tanaka Y; Nishida N; Sugiyama M; Kurosaki M; Matsuura K; Sakamoto N; Nakagawa M; Korenaga M; Hino K; Hige S; Ito Y; Mita E; Tanaka E; Mochida S; Murawaki Y; Honda M; Sakai A; Hiasa Y; Nishiguchi S; Koike A; Sakaida I; Imamura M; Ito K; Yano K; Masaki N; Sugauchi F; Izumi N; Tokunaga K; Mizokami M
Nat Genet; 2009 Oct; 41(10):1105-9. PubMed ID: 19749757
[TBL] [Abstract][Full Text] [Related]
9. IL28B polymorphism as a predictor of antiviral response in chronic hepatitis C.
Cieśla A; Bociąga-Jasik M; Sobczyk-Krupiarz I; Głowacki MK; Owczarek D; Cibor D; Sanak M; Mach T
World J Gastroenterol; 2012 Sep; 18(35):4892-7. PubMed ID: 23002361
[TBL] [Abstract][Full Text] [Related]
10. Lead-in treatment with interferon-β/ribavirin may modify the early hepatitis C virus dynamics in pegylated interferon alpha-2b/ribavirin combination for chronic hepatitis C patients with the IL28B minor genotype.
Itokawa N; Atsukawa M; Tsubota A; Kondo C; Hashimoto S; Fukuda T; Matsushita Y; Kidokoro H; Kobayashi T; Narahara Y; Nakatsuka K; Kanazawa H; Iwakiri K; Sakamoto C
J Gastroenterol Hepatol; 2013 Mar; 28(3):443-9. PubMed ID: 23173698
[TBL] [Abstract][Full Text] [Related]
11. Pegylated interferon (alone or with ribavirin) for chronic hepatitis C in haemodialysis population.
Espinosa M; Hernàndez J; Arenas MD; Carnicer F; Caramelo C; Fabrizi F
Kidney Blood Press Res; 2015; 40(3):258-65. PubMed ID: 25997572
[TBL] [Abstract][Full Text] [Related]
12. Association of interleukin 28B and mutations in the core and NS5A region of hepatitis C virus with response to peg-interferon and ribavirin therapy.
Hayashi K; Katano Y; Honda T; Ishigami M; Itoh A; Hirooka Y; Ishikawa T; Nakano I; Yoshioka K; Toyoda H; Kumada T; Goto H
Liver Int; 2011 Oct; 31(9):1359-65. PubMed ID: 21745312
[TBL] [Abstract][Full Text] [Related]
13. Interferon-λ3 polymorphisms in pegylated-interferon-α plus ribavirin therapy for genotype-2 chronic hepatitis C.
Ishiguro H; Abe H; Seki N; Sugita T; Aida Y; Itagaki M; Sutoh S; Shimada N; Furihata T; Tsubota A; Aizawa Y
World J Gastroenterol; 2015 Apr; 21(13):3904-11. PubMed ID: 25852275
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-28B polymorphisms on the SVR in the treatment of naïve chronic hepatitis C with pegylated interferon-α plus ribavirin: a meta-analysis.
Shi KQ; Liu WY; Lin XF; Fan YC; Chen YP; Zheng MH
Gene; 2012 Oct; 507(1):27-35. PubMed ID: 22842190
[TBL] [Abstract][Full Text] [Related]
15. Interferon-λ-related genes and therapeutic response in Chinese hepatitis C patients.
Zhang YY; Chen HB; Xu Y; Huang P; Wang J; Zhang Y; Yu RB; Su J
World J Gastroenterol; 2015 Apr; 21(13):4006-13. PubMed ID: 25852288
[TBL] [Abstract][Full Text] [Related]
16. Association of SNPs in interferon receptor genes in chronic hepatitis C with response to combined therapy of interferon and ribavirin.
Heidari Z; Shahzamani K; Ghanbari R; Tahamsebifar A
Acta Med Iran; 2014; 52(10):740-7. PubMed ID: 25369007
[TBL] [Abstract][Full Text] [Related]
17. Antiviral combination therapy with peginterferon and ribavirin does not induce a therapeutically resistant mutation in the HCV core region regardless of genetic polymorphism near the IL28B gene.
Toyoda H; Kumada T; Hayashi K; Honda T; Katano Y; Goto H; Kawaguchi T; Murakami Y; Matsuda F
J Med Virol; 2011 Sep; 83(9):1559-64. PubMed ID: 21739446
[TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphisms of vitamin D pathway predict antiviral treatment outcome in slow responder naïve patients with chronic hepatitis C.
Falleti E; Cmet S; Fabris C; Fattovich G; Cussigh A; Bitetto D; Ceriani E; Lenisa I; Dissegna D; Ieluzzi D; Rostello A; Pirisi M; Toniutto P
PLoS One; 2013; 8(11):e80764. PubMed ID: 24244713
[TBL] [Abstract][Full Text] [Related]
19. A single nucleotide polymorphism in IL28B affects viral evolution of hepatitis C quasispecies after pegylated interferon and ribavirin therapy.
Yuan H; Adams-Huet B; Petersen T; Attar N; Lee WM; Jain MK
J Med Virol; 2012 Dec; 84(12):1913-9. PubMed ID: 23080496
[TBL] [Abstract][Full Text] [Related]
20. Interleukin 27 polymorphisms in HCV RNA positive patients: is there an impact on response to interferon therapy?
Zicca E; Quirino A; Marascio N; Nucara S; Fabiani F; Trapasso F; Perrotti N; Strazzulla A; Torti C; Liberto MC; Focà A
BMC Infect Dis; 2014; 14 Suppl 5(Suppl 5):S5. PubMed ID: 25236666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]